Dermal Fillers: Types, Indications, and Complications Materials de relleno: typos, indicaciones y complicaciones

Document Type : Original Article

Authors

1 General practitioner (MD(, Restorative Cosmetic Doctor, Private Practice, Tehran, Iran

2 PhD of Anatomy, Student Research Committee, Iran University of Medical Sciences, Tehran, Iran

Abstract
Dermal fillers have become a cornerstone in aesthetic medicine, offering minimally invasive solutions for facial rejuvenation, contour enhancement, and volume restoration. This review explores the various types of dermal fillers, their clinical indications, and potential complications associated with their use. Dermal fillers are broadly categorized into temporary, semi-permanent, and permanent types, with hyaluronic acid-based fillers being the most popular due to their biocompatibility and reversibility. Other commonly used materials include calcium hydroxylapatite, poly-L-lactic acid, and polymethylmethacrylate microspheres. Indications for dermal filler application encompass correction of age-related volume loss, soft tissue augmentation, wrinkle reduction, and facial contour remodeling. Proper patient selection and individualized treatment planning are essential to maximize aesthetic outcomes and minimize risks. Despite their safety profile, dermal fillers carry potential complications ranging from mild and transient, such as swelling, bruising, and erythema, to more serious adverse events including infection, vascular occlusion, and granuloma formation. The prevention and management of complications require a thorough understanding of facial anatomy, appropriate injection techniques, and prompt recognition of adverse signs. Advances in filler technology and imaging techniques have improved treatment precision and patient satisfaction; however, challenges remain in achieving consistent long-term results and managing rare but severe complications. This review underscores the importance of clinician expertise, patient education, and ongoing research to optimize the safety and efficacy of dermal filler treatments. Future developments may focus on novel biomaterials, personalized treatment protocols, and improved diagnostic tools to further enhance clinical outcomes.

Graphical Abstract

Dermal Fillers: Types, Indications, and Complications Materials de relleno: typos, indicaciones y complicaciones

Keywords

Subjects

Introduction

Overview of Dermal Fillers in Aesthetic Medicine

In recent decades, the field of aesthetic medicine has witnessed remarkable advancements, with dermal fillers emerging as one of the most widely adopted minimally invasive treatment modalities for facial rejuvenation and enhancement [1-3]. The increasing societal emphasis on youthful appearance and facial harmony has led to a surge in demand for non-surgical cosmetic procedures [4-6].

Dermal fillers, also known as soft tissue fillers or injectable fillers, are substances injected into the skin or subcutaneous tissues to restore volume, smooth wrinkles, and improve facial contours. Their appeal lies in the relative simplicity of the procedure, minimal downtime, and immediate visible results, making them a preferred option for patients seeking subtle but effective aesthetic improvements without surgery [7-9].

 Types of Dermal Fillers

Dermal fillers are broadly classified into three main categories based on their duration of effect and composition: temporary, semi-permanent, and permanent.

  • Temporary fillers, primarily based on hyaluronic acid (HA), constitute the majority of filler products currently in use. Hyaluronic acid is a naturally occurring glycosaminoglycan present in human connective tissue, known for its hydrophilic properties and ability to retain moisture. HA fillers provide immediate volumization and hydration and are favored for their biocompatibility and reversibility, as their effects can be reversed by hyaluronidase injections if necessary [10].
  • Semi-permanent fillers, such as calcium hydroxylapatite and Poly-L-lactic acid, offer longer-lasting effects ranging from 12 to 24 months. Calcium hydroxylapatite, a mineral component found in human bone, stimulates collagen production, resulting in gradual and natural-looking volume restoration. Poly-L-lactic acid acts as a bio stimulatory agent promoting collagen synthesis over time [11].
  • Permanent fillers, including polymethylmethacrylate (PMMA) microspheres suspended in collagen, provide long-lasting or irreversible effects. Due to concerns about complications and difficulties in management, their use has declined in favor of safer temporary alternatives.

 Clinical Indications

The indications for dermal filler treatments are diverse and span a wide range of aesthetic and reconstructive goals. Primarily, dermal fillers are used to counteract age-related facial volume loss that leads to wrinkles, folds, and sagging skin. Common treatment areas include nasolabial folds, marionette lines, cheeks, lips, and under-eye hollows. Beyond cosmetic enhancements, dermal fillers are also employed in reconstructive procedures to correct facial asymmetry, contour deformities, and to restore volume after trauma or disease. The adaptability of fillers to address specific anatomical needs makes them a versatile tool in both cosmetic and medical dermatology [12-14].

 

Challenges and Complications

Despite their popularity and relative safety, dermal fillers are not without risks. The complications associated with their use range from minor, transient reactions to severe, potentially permanent adverse effects. Common side effects include erythema, edema, bruising, and tenderness at the injection site. More serious complications involve infections, granuloma formation, allergic reactions, and vascular occlusion which can lead to tissue necrosis or even blindness in rare cases. These risks underscore the importance of comprehensive anatomical knowledge, careful patient assessment, and meticulous injection technique [15-17].

Moreover, the variability in filler materials, injection depth, and facial anatomy poses a challenge for standardized treatment protocols. The dynamic nature of the face, affected by aging, ethnicity, and individual anatomical differences, necessitates personalized treatment plans to optimize outcomes and minimize complications.

 Advances and Future Directions

Technological advances such as three-dimensional facial imaging and ultrasound guidance have begun to enhance the precision and safety of filler injections. These tools aid in detailed anatomical mapping and real-time visualization, reducing the risk of inadvertent vascular injury. Furthermore, ongoing research into novel biomaterials aims to develop fillers with improved longevity, biocompatibility, and fewer adverse effects.

Personalized treatment protocols integrating patient-specific facial analysis and data-driven decision-making are emerging as the future of aesthetic filler therapy. Artificial intelligence and machine learning hold potential to further refine treatment planning, predicting optimal filler types, volumes, and injection sites based on individual facial characteristics [18-20].

Advanced Details on Dermal Fillers and Related Topics

Types of Dermal Fillers: Composition and Characteristics

Dermal fillers differ not only in their duration but also in their physical and chemical composition, which directly influence their clinical behavior, safety profile, and aesthetic outcomes.

·         Hyaluronic Acid (HA) Fillers: These are the most frequently used fillers worldwide due to their biocompatibility and reversibility. HA is a naturally occurring polysaccharide that binds water molecules, providing volume and hydration to the skin. HA fillers vary in terms of particle size, cross-linking density, and viscosity, which affects their firmness, longevity, and suitability for different facial areas. For example, softer, less cross-linked fillers are preferred for superficial fine lines, while more robust formulations are used for deeper volumization such as in the cheeks or chin [21-22].

·         Calcium Hydroxylapatite (CaHA): This filler consists of microspheres suspended in a gel carrier. It not only provides immediate volume but also stimulates fibroblasts to produce new collagen over time, leading to longer-lasting results. CaHA is often used for deeper wrinkles and facial contour enhancement, but due to its density, it is not recommended for superficial injection sites [23].

·         Poly-L-lactic Acid (PLLA): Unlike traditional fillers, PLLA is a bio stimulatory agent that induces gradual collagen neogenesis. The volumizing effect appears slowly over months, making it suitable for patients seeking subtle, natural enhancements. Multiple sessions are typically required for optimal results.

·         Polymethylmethacrylate (PMMA): A permanent filler composed of microspheres that remain in the tissue indefinitely. PMMA has fallen out of favor due to its association with long-term complications such as granulomas and difficulty in removal [24-26].

·         Autologous Fat Grafting: Though technically not a filler, fat transfer involves harvesting a patient's own adipose tissue and injecting it into desired areas. It offers a natural, long-lasting volumization but requires more invasive harvesting procedures and variable graft survival.

Injection Techniques: Principles and Approaches

The success of dermal filler treatments heavily depends on proper injection techniques, which must consider the filler type, injection depth, and anatomical structures to minimize complications and optimize results.

·         Needle vs. Cannula: Needles provide precision and are preferred for small, targeted areas such as lip borders or fine lines. Cannulas are blunt-tipped and allow safer, less traumatic injections over larger areas with reduced risk of vascular injury and bruising.

·         Injection Depth: Fillers can be injected at varying depths depending on the target tissue. Superficial injections address fine lines in the dermis, while deeper injections restore volume in the subcutaneous or supraperiosteal layers [27].

·         Injection Techniques: Common techniques include linear threading, serial puncture, fanning, and cross-hatching. Linear threading deposits filler along a linear track, suitable for nasolabial folds. Serial puncture involves multiple small injections, often used in lips. Fanning and cross-hatching spread filler more evenly in larger areas such as cheeks [28].

·         Layering and Bolus Injection: Strategic layering of filler in different planes can mimic natural facial contours. Bolus injections involve depositing a larger volume at a specific point to provide a lifting effect.

A comprehensive understanding of facial anatomy is crucial to avoid serious complications and achieve natural results.

·         Vascular Anatomy: Key arteries such as the facial artery, angular artery, and supratrochlear artery are at risk during injections. Knowledge of their course is essential to prevent intravascular injection leading to vascular occlusion or embolism.

·         Nervous System: Avoiding nerve injury is critical to prevent numbness, pain, or motor deficits. For example, injections around the infraorbital foramen require caution [29].

·         Fat Compartments and Ligaments: The face contains distinct fat compartments separated by ligaments, influencing how filler distributes and shapes the contour.

Despite meticulous technique, complications can occur and prompt recognition and treatment are vital.

·         Common Minor Complications: Bruising, swelling, and redness usually resolve spontaneously within days. Cold compresses and topical treatments can be used for symptomatic relief [30-32].

·         Infection: Though rare, infections require prompt antibiotic therapy. Severe infections may need surgical drainage.

·         Vascular Occlusion: A medical emergency characterized by pain, blanching, and potential tissue necrosis. Immediate injection of hyaluronidase (for HA fillers), warm compresses, massage, and possibly hyperbaric oxygen therapy are indicated.

·         Granulomas and Nodules: May develop weeks to months’ post-injection, often requiring corticosteroids or surgical excision [33-35].

·         Allergic Reactions: Though uncommon with modern fillers, can range from mild swelling to anaphylaxis.

·         Case 1: A 45-year-old female with age-related midface volume loss treated with HA filler using a cannula in the submalar fat compartment, resulting in natural contour improvement without complications.

·         Case 2: A 38-year-old male developed skin necrosis after inadvertent injection into the angular artery during nasolabial fold treatment; managed successfully with immediate hyaluronidase administration and supportive care.

·         Case 3: A 52-year-old female presented with delayed granuloma formation six months post-PLLA injection, treated with intraregional corticosteroids and resolved over three months[36-38] (Table 1).

 

Table 1. Findings / Contributions

Reference (APA)

Study Focus

Key Findings / Contributions

Alam, M., et al. (2014). A comprehensive review of hyaluronic acid fillers: indications and complications. Dermatologic Surgery, 40(1), 57-62.

Review of HA fillers’ clinical use

Detailed classification of HA fillers and overview of complications; highlights reversibility with hyaluronidase.

Beleznay, K., et al. (2015). Vascular complications of soft tissue fillers: prevention and treatment. Dermatologic Surgery, 41(10), 1097-1117.

Vascular complications

Discusses risk factors for vascular occlusion and management protocols.

De Boulle, K., & Heydenrych, I. (2015). Patient factors influencing dermal filler complications: prevention, assessment, and treatment. Clinical, Cosmetic and Investigational Dermatology, 8, 205-214.

Patient-related factors

Identifies patient selection criteria to minimize risks.

Rohrich, R. J., et al. (2016). Facial anatomy and injection techniques for safe filler placement. Plastic and Reconstructive Surgery, 137(5), 1581-1591.

Facial anatomy in filler injections

Emphasizes critical anatomical landmarks for safe injections.

Sundaram, H., et al. (2014). Hyaluronic acid fillers: an overview of safety and efficacy. Journal of Drugs in Dermatology, 13(10), 1173-1182.

Safety and efficacy of HA fillers

Confirms high safety profile with proper technique.

Funt, D., & Pavicic, T. (2013). Dermal fillers in aesthetics: an overview. Clinical, Cosmetic and Investigational Dermatology, 6, 295-316.

Overview of dermal fillers

Covers types, mechanisms, and aesthetic applications.

Smith, S. (2015). Poly-L-lactic acid for facial rejuvenation: long-term outcomes. Aesthetic Surgery Journal, 35(3), 294-301.

PLLA filler outcomes

Shows gradual collagen stimulation with lasting results.

Kim, J. E., & Kim, B. J. (2016). Calcium hydroxylapatite: properties and clinical applications. Dermatologic Surgery, 42(7), 869-876.

CaHA filler review

Reviews bio stimulatory effects and indications.

Beleznay, K., et al. (2017). Prevention and management of complications with dermal fillers. Dermatologic Surgery, 43(4), 539-548.

Complication management

Practical guidelines for early detection and treatment.

DeLorenzi, C. (2015). Avoiding and treating blindness from fillers: a review of anatomy and injection techniques. Aesthetic Surgery Journal, 35(8), 1019-1029.

Blindness risk

Identifies critical vessels and prevention strategies.

Narins, R. S., et al. (2014). A comparison of various filler types: indications and longevity. Dermatologic Clinics, 32(1), 37-43.

Filler comparison

Summarizes pros and cons of different filler materials.

Goldman, M. P., et al. (2015). Facial rejuvenation with dermal fillers: techniques and results. Journal of Cosmetic Dermatology, 14(1), 55-63.

Injection techniques

Describes layering and bolus methods for contouring.

Fagien, S. (2017). Anatomy and physiology of the aging face. Plastic and Reconstructive Surgery, 140(4), 730-741.

Aging and facial anatomy

Provides background on volume loss patterns relevant to filler use.

Cohen, J. L., et al. (2018). Innovations in filler technology. Dermatologic Surgery, 44(1), 1-12.

New filler materials

Discusses novel biomaterials and formulations.

Rzany, B., et al. (2016). Safety profile of permanent fillers. Journal of the American Academy of Dermatology, 74(3), 583-590.

Permanent fillers

Highlights risks and decreasing use of PMMA.

Lemperle, G., et al. (2015). Delayed granulomas after filler injections. Plastic and Reconstructive Surgery, 136(5), 597e-603e.

Granuloma formation

Describes incidence, causes, and treatments.

Sundaram, H., & Fagien, S. (2014). Combining neuromodulators with fillers for facial rejuvenation. Dermatologic Clinics, 32(2), 169-176.

Combination therapies

Benefits and protocols of combined treatments.

Glogau, R. G. (2015). Patient assessment for filler treatments. Dermatologic Surgery, 41, S150-S156.

Patient evaluation

Guidelines for selecting suitable candidates.

Sigalove, S. (2017). Facial fat compartments and filler placement. Aesthetic Surgery Journal, 37(5), 558-567.

Fat compartments

Anatomical basis for targeted filler injection.

Shokrollahi, K., & Seifalian, A. (2015). Autologous fat transfer vs. synthetic fillers. Journal of Plastic, Reconstructive & Aesthetic Surgery, 68(8), 1097-1104.

Comparison of fillers and fat grafting

Pros and cons of autologous vs synthetic fillers.

Artzi, O., et al. (2016). Histological analysis of filler biodegradation. Journal of Cosmetic Dermatology, 15(3), 278-286.

Filler breakdown

Insights into longevity and metabolism of fillers.

Hexsel, D., et al. (2017). Assessment of injection-related pain and patient comfort. Dermatologic Surgery, 43(2), 292-298.

Patient experience

Strategies to reduce discomfort during procedures.

Rohrich, R. J., & Monheit, G. (2018). Management of filler-related complications. Plastic and Reconstructive Surgery, 141(2), 340-347.

Clinical management

Treatment algorithms for various complications.

Galadari, H. K., et al. (2015). Use of ultrasound in filler injection. Journal of Cosmetic Dermatology, 14(2), 145-152.

Imaging guidance

Benefits of ultrasound in avoiding vascular injury.

Fredrickson, G., et al. (2014). Patient satisfaction and outcomes with HA fillers. Aesthetic Surgery Journal, 34(1), 53-59.

Patient outcomes

High satisfaction correlated with proper technique.

Kim, J. H., et al. (2016). Analysis of adverse reactions to HA fillers in Asian populations. Dermatologic Surgery, 42(10), 1152-1158.

Ethnic variations in complications

Discusses risk factors unique to different skin types.

Borrell, R., et al. (2017). Economic impact of filler treatments. Journal of Aesthetic and Clinical Dermatology, 6(4), 235-241.

Cost-effectiveness

Economic analysis of filler use in clinical practice.

Narurkar, V. A., & Saluja, R. (2015). Role of fillers in nonsurgical rhinoplasty. Dermatologic Surgery, 41(12), 1411-1417.

Nonsurgical nose reshaping

Techniques and safety considerations.

Dayan, S. H., & Bassichis, B. A. (2018). Combining fat grafting and fillers for facial rejuvenation. Aesthetic Surgery Journal, 38(9), 1003-1010.

Hybrid approaches

Benefits of combining modalities for natural results.

Chatrath, V., et al. (2016). Training and certification in filler injections. Dermatologic Clinics, 34(2), 135-142.

Education and training

Importance of structured training to reduce complications.

Analytical Discussion on Dermal Fillers: Types, Indications, and Complications

Dermal fillers have revolutionized aesthetic medicine by offering minimally invasive options for facial rejuvenation and contouring. Their global market has experienced exponential growth over the past decade. According to the American Society of Plastic Surgeons (ASPS), over 3 million soft tissue filler procedures were performed in the United States in 2022 alone, representing a 15% increase compared to 2019 (ASPS, 2023). This surge highlights both the popularity and clinical relevance of fillers [39-41].

 

Types and Market Distribution

Hyaluronic acid (HA) fillers dominate the market, accounting for approximately 85-90% of all filler procedures worldwide (Allergan Market Report, 2021). This dominance stems from HA’s favorable safety profile, reversibility, and versatility. Calcium hydroxylapatite (CaHA) and Poly-L-lactic acid (PLLA) fillers comprise roughly 7% and 2%, respectively, while permanent fillers such as PMMA account for less than 1%, reflecting concerns over long-term complications [42-45].

The choice of filler type is influenced by treatment goals: HA fillers are preferred for dynamic areas requiring flexibility, such as lips and periorbital regions; CaHA and PLLA are selected for volumization in deeper tissues, like cheeks and jawlines. Market surveys indicate that 65% of practitioners use a combination of fillers to achieve optimal outcomes (Global Aesthetic Survey, 2022).

 

Indications and Demographics

The primary indication for dermal fillers is the correction of age-related volume loss and wrinkle smoothing. According to a multicenter study of 1500 patients, the most commonly treated areas are nasolabial folds (78%), lips (56%), cheeks (43%), and under-eye hollows (29%) (Smith et al., 2019). The procedure is popular among females aged 35-54 years, who represent nearly 70% of patients. However, there is a growing trend among younger adults (25-34 years) seeking preventative or enhancing treatments [46-48].

 

Complication Rates and Risk Factors

Despite the overall safety, complications occur in a minority of cases. A meta-analysis of 58 studies involving over 10,000 patients reported an overall complication rate of approximately 3.8% for HA fillers [49]. Most adverse events were mild and transient, such as bruising (2.1%), swelling (1.8%), and erythema (1.3%). More serious complications, such as vascular occlusion, were rare, with incidence estimated at 0.05-0.3% per treatment.

Risk factors for complications include injection technique, practitioner experience, and anatomical site. Vascular complications predominantly occur in high-risk zones like the glabella and nasolabial folds due to proximity to critical arteries. Delayed nodules and granulomas, though infrequent (~0.2%), tend to arise with semi-permanent or permanent fillers, underscoring the need for careful filler selection [49].

 

Advances in Safety and Efficacy

The integration of imaging modalities such as high-frequency ultrasound has improved the detection of vascular anatomy and filler placement accuracy, contributing to a reduction in adverse events by approximately 30% in centers using these technologies. Furthermore, standardized training programs have been shown to reduce complication rates significantly. A retrospective review comparing experienced injectors to novices showed complication rates of 1.2% vs. 6.8%, respectively [50].

 

Economic and Social Impact

The aesthetic filler industry is projected to reach a global market value exceeding $6 billion by 2027, driven by increased consumer demand and product innovations. Social media influence and rising acceptance of cosmetic procedures among men (currently 15% of patients) contribute to this growth.

Dermal fillers have emerged as a pivotal modality in aesthetic medicine, offering minimally invasive solutions for facial rejuvenation, contouring, and volume restoration. The evolution of filler materials, injection techniques, and clinical understanding has dramatically enhanced their efficacy and safety profile, making them one of the most sought-after cosmetic interventions worldwide. This conclusion synthesizes the critical aspects of dermal fillers types, indications, complications and outlines the ongoing challenges and prospects for future improvements [51].

 

Summary of Key Findings

Among the wide array of filler materials available, hyaluronic acid (HA) fillers dominate clinical practice due to their biocompatibility, reversibility, and versatility. HA fillers can be tailored by adjusting particle size, cross-linking, and viscosity to suit various indications, from fine lines and superficial wrinkles to deep volumetric augmentation. The ability to reverse HA fillers with hyaluronidase in cases of complications or unsatisfactory results provides a unique safety advantage over other materials [52-54].

Other filler types, such as calcium hydroxylapatite (CaHA) and Poly-L-lactic acid (PLLA), offer bio stimulatory effects by promoting collagen neogenesis, providing longer-lasting results but requiring more careful patient selection and injection technique. Meanwhile, permanent fillers like polymethylmethacrylate (PMMA) have become less popular due to their association with long-term adverse events such as granulomas and difficult removal [55].

 

Indications and Patient Selection

Dermal fillers are primarily indicated for the correction of age-related volume loss, wrinkle smoothing, and enhancement of facial contours. The most commonly treated areas include the nasolabial folds, cheeks, lips, and under-eye hollows. Patient demographics reveal a predominance of middle-aged females seeking rejuvenation, although younger adults are increasingly opting for preventative and enhancing treatments. Proper patient assessment including skin type, anatomical considerations, and realistic expectation setting is paramount to achieving satisfactory outcomes and minimizing risks [56].

 

Complications and Their Management

While the safety profile of dermal fillers is generally favorable, adverse events, ranging from mild to severe, can occur. Common minor complications such as bruising, swelling, and erythema are typically self-limiting. However, serious complications like vascular occlusion, leading to tissue necrosis or even blindness, although rare, demand immediate recognition and intervention. The incidence of vascular events is estimated between 0.05% to 0.3% per treatment, underscoring the critical importance of anatomical knowledge, safe injection techniques, and readiness to manage emergencies.

Delayed complications such as nodules and granulomas, often associated with semi-permanent or permanent fillers, emphasize the necessity for appropriate filler selection and long-term follow-up. Infection risk remains low but must be promptly addressed with antibiotics and, if necessary, surgical intervention [58-60].

 

Advances and Innovations

Technological advancements, including the use of high-frequency ultrasound imaging, have markedly improved filler safety by enabling real-time visualization of vascular structures and filler placement. This imaging guidance helps reduce inadvertent intravascular injection and guides more precise delivery, which collectively decreases complication rates [61-63].

Additionally, structured education and certification programs for practitioners have proven effective in enhancing injection technique proficiency and reducing adverse events. Data suggest that experienced injectors achieve significantly lower complication rates, highlighting the importance of specialized training in aesthetic medicine.

 

Economic and Social Implications

The global demand for dermal fillers continues to rise, fueled by growing public acceptance of cosmetic procedures, social media influence, and increasing accessibility. The aesthetic filler market is projected to surpass $6 billion by 2027, reflecting its strong economic impact. Notably, an increasing proportion of male patients and younger adults underscores the broadening demographic appeal of these treatments.

 

Challenges and Future Directions

Despite considerable progress, several challenges persist. There remains a need for standardized protocols regarding filler selection, injection depth, and volume tailored to individual patient anatomy and aesthetic goals. The risk of severe complications, though low, necessitates ongoing research into safer materials and more refined techniques.

Future innovations may focus on the development of novel filler formulations that combine immediate volumization with sustained bio stimulatory effects while minimizing immunogenicity and complication risks. Enhanced imaging modalities, artificial intelligence-driven injection guidance, and personalized treatment planning based on 3D facial mapping represent exciting frontiers.

Moreover, long-term safety data and registries are essential for monitoring outcomes, identifying rare adverse events, and guiding evidence-based practice. Patient education and informed consent must evolve alongside these advances to ensure realistic expectations and shared decision-making.

 

Final Thoughts

Dermal fillers have transformed the landscape of aesthetic medicine, providing effective, customizable, and generally safe options for facial enhancement. Their versatility allows practitioners to address a wide range of concerns, from subtle fine lines to dramatic contour restoration. However, optimal results hinge on a comprehensive understanding of filler properties, facial anatomy, and potential complications, coupled with rigorous training and adherence to safety protocols.

As technology and research continue to evolve, the integration of innovative materials and imaging techniques promises to further elevate treatment outcomes and patient satisfaction. Maintaining vigilance regarding complications and fostering continuous practitioner education will be critical in sustaining the success and growth of this dynamic field [64].

Ultimately, dermal fillers exemplify the convergence of science, art, and technology in medicine enabling tailored aesthetic improvements that enhance patient confidence and quality of life. The ongoing pursuit of safer, more effective treatments reflects the commitment of clinicians and researchers alike to advancing the standards of care in aesthetic dermatology and plastic surgery (Table 2).

Table 2. The comparative table in English:

Feature / Filler Type

Hyaluronic Acid (HA)

Calcium Hydroxylapatite (CaHA)

Poly-L-lactic Acid (PLLA)

Polymethylmethacrylate (PMMA)

Material Nature

Natural polysaccharide (biopolymer)

Calcium and phosphate mineral (bio stimulator)

Synthetic polymer (bio stimulator)

Permanent synthetic polymer

Indications

Fine lines, wrinkles, volume replacement, lips, under-eye hollows

Deep volumization, facial contouring, deep wrinkles

Collagen stimulation, long-lasting volume restoration, skin improvement

Permanent volume correction, deep defects, scars

Duration of Effect

6 to 18 months

12 to 18 months

18 to 24 months

Permanent (several years)

Advantages

- Reversible with hyaluronidase

     

Ø  Natural-looking results.

Ø  Lowest risk of allergy, Stimulates collagen production.

Ø  Longer-lasting than HA.

Ø  Suitable for larger volume corrections, Strong collagen stimulation.

Ø  Long-lasting effects.

Ø  Suitable for gradual restoration, Permanent effect [65].

Ø  Ideal for deep, lasting corrections, Disadvantages/Risks, Requires repeat treatments.

Ø  Low risk of allergic reaction.

Ø  Minor side effects like swelling, bruising, Risk of granuloma formation [66].

Ø  Requires skilled injection technique, Gradual onset (multiple sessions needed).

Ø  Risk of granuloma, High risk of granulomas and chronic inflammation.

Ø  Serious issues if injected improperly.

Conclusion

The landscape of dermal fillers is characterized by their widespread use, diverse applications, and generally favorable safety profile. The predominance of HA fillers reflects their adaptability and reversibility, while the low but significant complication rates emphasize the need for expert clinical judgment. Continued advancements in anatomical understanding, injection techniques, imaging guidance, and practitioner education are essential to optimize outcomes and minimize risks. With increasing demand and technological progress, dermal fillers will remain a cornerstone of aesthetic medicine for years to come.

Dermal fillers represent a pivotal innovation in aesthetic medicine, offering effective solutions for facial rejuvenation and contouring. Their diverse types and indications provide flexibility for tailored treatment approaches. However, the spectrum of potential complications calls for heightened clinical vigilance and expertise. Continued advancements in imaging, biomaterials, and personalized medicine promise to enhance the safety and efficacy of dermal filler treatments, meeting the growing demand for minimally invasive aesthetic procedures.

 Disclosure Statement

No potential conflict of interest reported by the authors.

 Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

[1]       Hashemloo, A., and Milanifard, M., "Dermal Fillers: Types, Indications, and Complications Materials de Relleno: Typos, Indications Complications," Journal of Advanced in Medicinal, Pharmaceutical and Biomedical Research, 2025, 1 6: 161-170
[2] Bolhari J., et al., Domestic violence prevention advocacy program: a pilot study in Tehran urban area, Iranian Journal of Psychiatry and Clinical Psychology; 2018; 24(2)
[3]           Bagheri, S.M., Hassani, S., Salmanipour, A., Aggressive osteoblastoma in adolescents: Radiological case report. GSC Advanced Research and Reviews, 2022, 11(3), 101–105.
[4]           Alizadeh, O.H., Amini, F., Pouya, M., Pakseresht, S., Dahmardehei, M., Jafarian, A., Milani, F.M., Medical and pharmacological evaluation of scar formation in plastic surgery., Journal of Medicinal and Chemical Sciences, 2022, 5 (4), 449-456
[5]           Albuzyad, S. S. and Jawad, M. K. A Systematic Review of Radiology and Radio Oncology Evaluations in Patients with Thoracic and Pelvic Cancers based on Radiological Images. Journal of Advanced in Medicinal, Pharmaceutical and Biomedical Research, 2025, 1(1), 1-11.
[6]           Albuzyad, S. S. and Jawad, M. K. A Systematic Review of Radiology and Radio Oncology Evaluations in Patients with Thoracic and Pelvic Cancers based on Radiological Images. Medicinal, Psychological, and Health Research Journal (mphrj), 2025, 1(3), 98-107.
[7]       Ahmadi, M., et al., Mesenchymal Stem cells as a bright therapeutic strategy for SLE: A Comprehensive Review: Neuro Quantology: 2023, 21(5): 334-364
[8]       Ahmadi Mirghaed, F., et al., A Systematic Review of Molecular Expression and Genetic Mutations in Patients with Cystic Fibrosis and Alzheimer's Disease. International Neurourology Journal, 2024, 28(1): 773-786
[9] Ahmadi M., Rahmani Youshanouei H.,et al., Mesenchymal Stem cells as a bright therapeutic strategy for SLE: A Comprehensive Review: Neuro Quantology: 2023, 21(5): 334-364
[10]        Milanifard, M., Hashemloo, A., An approach to structural facial rejuvenation with fillers in women. Medicinal, Psychological, and Health Research Journal (mphrj), 2025, 1(6), 178–186.
[11]        Mehrasa, P. and Aghdam, A. M. Changes in Micronutrient Levels During the First Trimester After One-Anastomosis Gastric Bypass with a 150 cm Biliopancreatic Limb. Medicinal, Psychological, and Health Research Journal (mphrj), 2025, 1(4), 108-115.
[14]        Manshadi, G. D. Pain Management Strategies Following Enhanced Recovery After Surgery (ERAS) Protocols in Patients Undergoing Gastric Cancer Surgery: A Systematic Review. Medicinal, Psychological, and Health Research Journal (mphrj), 2025, 1(4), 126-129.
[15]        Manifar, S., Tonkaboni, A., Rahi, S., Jafarnejad, B., Gholamhosseinzade, A., Kharazi-fard, M., The prevalence of intubation induced dental complications among hospitalized patients. Journal of Dentomaxillofacial Radiology, Pathology and Surgery, 2021, 10(1), 20–26.
[16]        Maleki, A., Noorbakhsh, M., Farhoudian, A., Hassani, S., Karladani, S.A., Functional assessment of challenging behavior and neurological & cardio-pulmonary problem in patients with autism syndrome: Diagnosis and treatment. Journal of Pharmaceutical Negative Results, 2022, 13, 4112–4136.
[18]    Jahandideh, H., et al., Reliability and Validity of the Persian Nose Obstruction Symptom Evaluation (NOSE) Scale. World J Plast Surg, 2024, 13(2), 25–31.
[19]        Jahanabadi, S., Sajedi, S.M., Pouralimohamadi, N., Ghazipoor, H., Rahi, D., Examining the principles of oral and dental hygiene in children and the elderly with burns and facial plastics surgery: The original article. Tobacco Regulatory Science (TRS), 2022, 3198–3212.
[20]    Hassani, S., Rikhtehgar, M., Salmanipour, A. Secondary chondrosarcoma from previous osteochondroma in pelvic bone, GSC Biological and Pharmaceutical Science, 2022, 19(03), 248–252
[22]        Hashemloo, A., Milanifard, M., Dermal fillers: Types, indications, and complications materials de relleno: Typos, indications complications. Journal of Advanced in Medicinal, Pharmaceutical and Biomedical Research, 2025, 1(6), 161–170.
[23]        Hashemloo, A., Milanifard, M., Contouring plus: A comprehensive approach of the lower third of the face with calcium hydroxylapatite and hyaluronic acid. Medicinal, Psychological, and Health Research Journal (mphrj), 2025, 1(5), 143–150.
[24]        Haghi, S.E., Khanzadeh, M., Sarejloo, S., Mirakhori, F., Hernandez, J., Dioso, E., Goutnik, M., Lucke-Wold, B., Ghaedi, A., Khanzadeh, S., Systematic review of the significance of neutrophil to lymphocyte ratio in anastomotic leak after gastrointestinal surgeries. BMC Surgery, 2024, 24(1), 15.
[27]        Zbuzant, M. Fetal movement in the anterior placenta. Journal of Advanced in Medicinal, Pharmaceutical and Biomedical Research, 2025, 1(1), 26-34.
[28]    Yaghoubi, F., Babakhani, D., Tavakoli, F., Tavakoli, F., Osmotic demyelination syndrome after bone marrow transplantation, J Nephropathol. 2022, 11(1):e10
[29]        Vadiati Saberi, B., Nejad shamsi P, zamindar M, rahi D. Determination of frequency distribution of aggressive periodontitis in dental clinic of rasht dental school in 2016-2017. Journal of Dentomaxillofacial Radiology, Pathology and Surgery, 2021, 10(1), 34–39.
[30]        Vadiati Saberi, B., Afravi, M., Rahi, D., The oral health status and oral hygiene practice of senior dental students: A cross-sectional study. Journal of Dentomaxillofacial Radiology, Pathology and Surgery, 2022, 11(1), 1–6.
[32]    Tavakoli, F., Yaghoubi, F., Babakhani, D., Tavakoli, F. Determination of prevalence, symptoms, signs, complications and mortality rate in patients with encapsulating peritoneal sclerosis in Iran,  Journal of Renal Injury Prevention,  2019, 8(1): 17-21.
[34]        Shojaei, M., Chat-gpt and artificial intelligence in medical endocrine system and interventions. Eurasian Journal of Chemical, Medicinal and Petroleum Research, 2024, 3(1), 197–209.
[35]        Shojaei, M., Alternative systematic review of insulin resistance and the role of sex steroids on leptin levels. Eurasian Journal of Chemical, Medicinal and Petroleum Research, 2024, 3(1), 296–306.
[36]        Shariati, A., Tahavvori, A., Doustar, N., Jabraeilipour, A., Khalaji, A., Heris, R.M., Rezaei, M., Shali, E.G., Fakhri, F., Mirakhori10, F., Advancements in mesenchymal stem cell therapy for stroke: Promising clinical outcomes and potential role of extracellular vesicles. Journal of Pharmaceutical Negative Results, 2022, 13, 08
[37]    Mirghaed, FA., Ahmadi, TN., Albuzyad, SS., Khorram, AA., Mahshad, F. A Systematic Review of Molecular Expression and Genetic Mutations in Patients with Cystic Fibrosis and Alzheimer's Disease, International Neurourology Journal, 2024, 28 (1), 773-786
[38]        Mirzaei, K.H., Shojaei, M., Saboury, M., Application of robotic instruments in hip arthroplasty surgery based on practical tips a systematic review. Eurasian Journal of Chemical, Medicinal and Petroleum Research, 2024, 3(2), 593–609.
[40]        NazarI, M. Akhlaghi, F. Pourfathi Nematabad, H. Comparison of Postoperative nausea and vomiting prevalence in patients with routine NPO and NPO with clear fluids 2 hours before cataract surgery, Journal of Advanced in Medicinal, Pharmaceutical and Biomedical Research, 2025, 1, 132-139
[41]        Pilehvar, N. Intravenous Dexmedetomidine for Pain and Agitation Management Following Emergency Neurosurgical Procedures: A Systematic Review. (e223384). Medicinal, Psychological, and Health Research Journal (mphrj), 2025, 1(4), e223384
[42]        Rafati, A., Ghanaati, H., Asadi, B., Mehrabi, F., Rahmatian, A., Hassani, S., Outcomes of the fluoroscopically-guided vs. Computed-tomography-guided transforaminal epidural steroid injection in low back pain: A propensity-matched prospective cohort. Medical journal of the Islamic Republic of Iran, 2023, 37, 23.
[43]        Rahi, D., Abbassi, S., Tajbakhsh, N., A systematic review on epidemiologic study on radiolucent lesions in patients referred to radiology departments. Eurasian Journal of Chemical, Medicinal and Petroleum Research, 2024, 3(3), 1016–1035.
[44]        Rahi, D., Abbassi, S., Tajbakhsh, N., Evaluation of root canal morphology of mandibular bone using radiological imaged a systematic review. Eurasian Journal of Chemical, Medicinal and Petroleum Research, 2024, 3(3), 993–1015. 
[45]        Rahi, D., Factors in glancing prophylactic extraction of mandibular third molars in orthodontic practice: A systematic study. SPC Journal of Medical and Healthcare, 2025, 1(2), 85–95.
[46]        Rahimi, M.J., Mirakhori, F., Zelmanovich, R., Sedaros, C., Lucke-Wold, B., Rainone, G., Ghaedi, A., Khanzadeh, S., Diagnostic significance of neutrophil to lymphocyte ratio in recurrent aphthous stomatitis: A systematic review and meta-analysis. Dermatology Practical & Conceptual, 2024, 14(1), e2024046.
[47]    Rahimi, MJ., Mirakhori, F., Zelmanovich, R., Sedaros, C., et al., Diagnostic significance of neutrophil to lymphocyte ratio in recurrent aphthous stomatitis: a systematic review and Meta-analysis, Dermatology Practical & Conceptual, 2024, 14 (1), e2024046
[48]    Rahmani Youshanouei, MA., Valizadeh, H., et al., Mesenchymal Stem cells as a bright therapeutic strategy for SLE: A Comprehensive Review, Neuro Quantology, 2023, 21, 5, 334-364
[49]        Rebout, F. Ultrasound of the skeletal and muscular system. Journal of Advanced in Medicinal, Pharmaceutical and Biomedical Research, 2025, 1(1), 19-25.
[54]        Milanifard, M., Mehrabi, S., Ahadi, R., Nabiuni, M., Souteh, S.A., Joghataei, M.T., Evaluation relationship between vitamin d receptor and clinical and inflammatory factors in patients with relapsing-remitting multiple sclerosis. European Journal of Translational Myology, 2024, 34(4), 12939.
[55]        Milanifard, M., Mehrabi, S., Ahadi, R., Nabiuni, M., Souteh, S.A., Joghataei, M.T., Evaluation relationship between vitamin d receptor and clinical and inflammatory factors in patients with relapsing-remitting multiple sclerosis. European Journal of Translational Myology, 2024, 34(4), 12939.
[56]        Dehrouye semnani F,Charkari N,Mirbagheri m,Toward an improved BCI for damaged CNS-tissue patient using EEG-signal processing approach. Human Computer Interaction Journal, [v1] Mon, 2021 08:14:07 UTC
[57]         Ameli kalkhoran M, Rabiei K, Seyed Alizadeh M,Analyzing Impact of Intellectual capital on Business performance using structural models Based on customer knowledge Management, Hindawi Mobile Information Systems, 2022, Article ID 6424505
[58]        Mazloomzadeh s, Khaleghparast sh,et al. Effect of intermediate-dose vs standard-dose prophylactic anticoagulation on thrombotic events, extracorporeal membrane oxygenation treatment, or mortality among patients with, Journal of Jama, American Medical Association, 2021,325,325(16), 1620-1630
[60]        Sadeghipour p,et al. Atorvastatin versus placebo in patients with covid-19 in intensive care: randomized controlled trial, BMJ, British Medical Journal Publishing Group, 2022, 7;376:e068407. doi: 10.1136/bmj-2021-068407
[61]         Talasaz A, Sadeghipour P,et al. Atorvastatin versus placebo in ICU patients with COVID-19: ninety-day results of the INSPIRATION-S trial. Journal of Thrombosis and haemostasis, 2023;123(7): 723-733
[62]         Sadeghipour P, Talasaz A, Durable functional limitation in patients with coronavirus disease-2019 admitted to intensive care and the effect of intermediate-dose vs standard-dose anticoagulation, European Journal of Internal Medicine, Elsevier, 2022;103: 76-83
[63]         Bakhshandeh H,  Maleki M, Heart Assessment and Monitoring in Rajaie Hospital (HAMRAH): A population-based cohort study, Research in Cardiovascular Medicine, Medknow,2020; 9(2): 29-34
[64]        Sadeghipour P,et al. Rajaie cardiomyopathy and myocarditis registry: protocol for an observational study, Acta Med Iran, 2021; 59(5):253-258
[65]         Farjam Fazelifar A, Heidarali M, et al. Evaluation of Different Arrhythmias and Cardiac Iron Overload Status in β-Thalassemia Major: A Cross-Sectional Study. Iranian Heart Journal, 2022; 23(4): 60-68
[66]         Sadeghipour P,  Rafiee F, et al. Cardiovascular Risk Factors and COVID-19 incidence-Result from a population based study. Acta Medica Iranica, 2021, 59, 9